메뉴 건너뛰기




Volumn 131, Issue 49 SUPPL. 9, 2006, Pages

Current recommendations for the diagnosis and treatment of pulmonary hypertension;Derzeitige empfehlungen zur diagnostik und therapie der pulmonalen hypertonie

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CALCIUM ANTAGONIST; CATECHOLAMINE; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTANOID; SILDENAFIL; SITAXSENTAN; UNIPROST;

EID: 33846271472     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-957206     Document Type: Review
Times cited : (5)

References (2)
  • 1
    • 0030853952 scopus 로고    scopus 로고
    • A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
    • Califf RM, Adams KF, McKenna WJ et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J 1997; 134: 44-54
    • (1997) Am Heart J , vol.134 , pp. 44-54
    • Califf, R.M.1    Adams, K.F.2    McKenna, W.J.3
  • 2
    • 0026632785 scopus 로고
    • The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
    • Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76-81
    • (1992) N Engl J Med , vol.327 , pp. 76-81
    • Rich, S.1    Kaufmann, E.2    Levy, P.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.